TLA for Allergic Asthma

About Airsonett

Airsonett is a commercial-stage medical device company offering a unique, clinically validated environmental control therapy for allergic diseases. Its core technology, TLA, is a CE-marked and FDA 510(k)-cleared Class I device that provides a zone of ultra-clean air during sleep, allowing the airways and immune system to recuperate. The treatment is recommended by several European health bodies and health economics studies position it as a cost-effective alternative or adjunct to pharmacological treatments. The company operates primarily in Sweden and the UK, with a business model based on device sales and rentals.

Therapeutic Areas